Molecules that control the release of a selenium-containing enzyme in the human body may become a tool to fight cancer.
Scientists effectively treated over 60 different types of cancer cells under laboratory conditions with these molecules.
Cancer Immunotherapy
Cancer immunotherapy is a new advancement in cancer treatment that uses certain components of a person''s immune system to fight against cancer cells.
Advertisement
‘Three different types of molecule that control the release of a selenium-containing enzyme can help fight oxidative stress and cancer.’
Tweet it Now
The study published in the US medical journal Science Translational Medicine said researchers at Karolinska Institute in Sweden treated cancer in mice with these molecules and observed rapid tumor-killing effects.
They have expressed hope that this new principle could be extended to treat cancer in humans, Xinhua news agency reported.
Selenium is a chemical element that is an essential micronutrient. A selenium-containing enzyme, called TrxR1, can be used to support the growth of various cells and protect them from oxidative stress.
![Laryngeal Cancer]( "Laryngeal Cancer")
Laryngeal cancer is also called cancer of the larynx or throat cancer or laryngeal carcinoma. It usually affects men over the age of 55 years.
Oxidative stress is the imbalance between the production of free radicals, which are highly reactive with other molecules, and the body's ability to counteract or to repair the resulting damage.
However, in several forms of cancer, raised levels of TrxR1 could be detected.
Researchers analyzed almost 400,000 different molecules to find new ones that would more specifically control TrxR1 and found three different types which proved to be active as anti-cancer medicines.
"This effectiveness against cancer may be a result of cancer cells' seemingly greater sensitivity to oxidative stress when compared to normal cells, which in turn can be utilized in cancer therapy," Elias Arner, a professor at the Karolinska Institute, who led the study, said.
"This seems to work in mouse models and we are therefore hopeful that this principle of treatment can be developed for humans, even if this will require many years of further research," he added.
Source: IANS
Selenium is a chemical element that is an essential micronutrient. A selenium-containing enzyme, called TrxR1, can be used to support the growth of various cells and protect them from oxidative stress.
Laryngeal Cancer
Laryngeal cancer is also called cancer of the larynx or throat cancer or laryngeal carcinoma. It usually affects men over the age of 55 years.
Advertisement
Oxidative stress is the imbalance between the production of free radicals, which are highly reactive with other molecules, and the body's ability to counteract or to repair the resulting damage.
However, in several forms of cancer, raised levels of TrxR1 could be detected.
Researchers analyzed almost 400,000 different molecules to find new ones that would more specifically control TrxR1 and found three different types which proved to be active as anti-cancer medicines.
"This effectiveness against cancer may be a result of cancer cells' seemingly greater sensitivity to oxidative stress when compared to normal cells, which in turn can be utilized in cancer therapy," Elias Arner, a professor at the Karolinska Institute, who led the study, said.
"This seems to work in mouse models and we are therefore hopeful that this principle of treatment can be developed for humans, even if this will require many years of further research," he added.
Source: IANS
Childhood Cancer
Childhood or pediatric cancers occur in children less than 15 years of age. They are rare and differ from adult tumors in their location and behaviour.
Advertisement
 | Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.
Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.
